Thierry Calandra Selected Research

Critical Care (Surgical Intensive Care)

2/2024	Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.
9/2017	Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
1/2014	Invasive candidiasis as a cause of sepsis in the critically ill patient.
11/2013	β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.
7/2012	Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.
11/2005	Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists.
7/2005	The international sepsis forum consensus conference on definitions of infection in the intensive care unit.
11/2004	Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.
4/2004	Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.
3/2004	Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thierry Calandra Research Topics

Disease

36	Sepsis (Septicemia) 02/2024 - 01/2003
30	Infections 02/2024 - 01/2005
18	Septic Shock (Toxic Shock Syndrome) 08/2022 - 01/2002
15	Neoplasms (Cancer) 12/2022 - 03/2002
10	Communicable Diseases (Infectious Diseases) 08/2022 - 03/2004
8	Critical Illness (Critically Ill) 02/2024 - 08/2005
8	Invasive Fungal Infections 09/2017 - 08/2005
8	Candidiasis (Moniliasis) 01/2014 - 10/2004
7	Leukemia 05/2022 - 03/2008
7	Shock 01/2021 - 01/2006
7	Inflammation (Inflammations) 01/2017 - 01/2003
7	Invasive Candidiasis 01/2014 - 02/2005
7	Mycoses (Diseases, Fungus) 01/2014 - 10/2004
6	Candidemia 08/2022 - 11/2005
6	Fever (Fevers) 03/2013 - 01/2005
4	HIV Infections (HIV Infection) 04/2022 - 01/2011
4	Febrile Neutropenia 01/2022 - 01/2005
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 04/2002
4	Aspergillosis 01/2017 - 08/2005
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2008 - 03/2004
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 03/2004
3	Endotoxemia 02/2024 - 05/2007
3	Lung Diseases (Lung Disease) 01/2021 - 08/2005
3	Pneumonia (Pneumonitis) 01/2019 - 07/2005
3	Neutropenia 01/2018 - 08/2005
3	Neonatal Sepsis 01/2017 - 07/2011
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 06/2009
3	Hemorrhage 01/2008 - 03/2004
3	Acute Lung Injury 01/2008 - 03/2004
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2008 - 03/2004
3	Ulcer 01/2008 - 03/2004
3	Rheumatoid Arthritis 10/2006 - 10/2005
2	Hematologic Neoplasms (Hematological Malignancy) 02/2023 - 01/2017
2	COVID-19 10/2022 - 01/2021
2	Bacterial Meningitis 01/2019 - 03/2016
2	Meningococcal Infections 02/2012 - 05/2007
2	Carcinogenesis 11/2009 - 12/2007
2	Peritonitis 03/2008 - 11/2005
2	Hypotension (Low Blood Pressure) 01/2008 - 01/2008
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2008 - 01/2008
1	Diabetes Mellitus 02/2023

Drug/Important Bio-Agent (IBA)

22	Macrophage Migration-Inhibitory FactorsIBA 01/2021 - 04/2002
16	CytokinesIBA 01/2021 - 01/2002
15	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 03/2004
8	AntibodiesIBA 03/2016 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2012
6	Fluconazole (Zonal)FDA LinkGeneric 01/2018 - 08/2005
6	Voriconazole (Vfend)FDA LinkGeneric 01/2017 - 11/2005
5	SteroidsIBA 01/2017 - 03/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2006
5	Protein CIBA 03/2008 - 03/2004
4	VaccinesIBA 01/2015 - 06/2009
4	Antifungal AgentsIBA 01/2014 - 11/2005
4	Proteins (Proteins, Gene)FDA Link 07/2012 - 01/2007
4	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2009 - 08/2005
3	EndotoxinsIBA 02/2024 - 01/2003
3	ProcalcitoninIBA 01/2021 - 04/2011
3	EchinocandinsIBA 01/2017 - 08/2005
3	GlucocorticoidsIBA 01/2017 - 05/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014 - 10/2006
3	Hormones (Hormone)IBA 02/2013 - 05/2007
3	MannansIBA 01/2010 - 02/2005
3	Caspofungin (Cancidas)FDA Link 05/2009 - 11/2005
3	Blood Glucose (Blood Sugar)IBA 01/2008 - 03/2004
3	Neuromuscular Blocking AgentsIBA 01/2008 - 03/2004
3	AzolesIBA 01/2008 - 08/2005
3	Hemoglobins (Hemoglobin)IBA 01/2008 - 03/2004
3	Dopamine (Intropin)FDA LinkGeneric 01/2008 - 03/2004
3	Crystalloid SolutionsIBA 01/2008 - 03/2004
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2008 - 03/2004
3	Dobutamine FDA LinkGeneric 01/2008 - 03/2004
3	Colloids (Colloid)IBA 01/2008 - 03/2004
2	Anti-Infective Agents (Microbicides)IBA 01/2021 - 03/2002
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 07/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 06/2009
2	AntigensIBA 01/2012 - 01/2010
2	Imipenem FDA Link 10/2009 - 09/2009
2	LipidsIBA 01/2009 - 10/2007
2	Proton Pump InhibitorsIBA 01/2008 - 01/2008
1	ORALIT (ORS)IBA 01/2023

Therapy/Procedure

36	Therapeutics 02/2024 - 10/2003
10	Critical Care (Surgical Intensive Care) 02/2024 - 03/2004
5	Resuscitation 01/2023 - 03/2004
5	Catheters 08/2022 - 07/2005
4	Drug Therapy (Chemotherapy) 11/2018 - 01/2005
3	Transplantation 05/2022 - 02/2004
3	Hemofiltration 01/2008 - 03/2004
3	Renal Dialysis (Hemodialysis) 01/2008 - 03/2004
3	Length of Stay 01/2008 - 10/2004
3	Analgesia 01/2008 - 03/2004
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2008 - 03/2004
2	Immunotherapy 01/2024 - 12/2022
2	Biological Therapy 05/2022 - 01/2022
2	Central Venous Catheters 01/2020 - 11/2005
2	Glycemic Control 01/2008 - 01/2008
2	Artificial Respiration (Mechanical Ventilation) 01/2008 - 01/2008
1	Immunomodulation 02/2024
1	Precision Medicine 01/2024
1	Organ Transplantation 02/2023